• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Phase 3, Open-Label, Safety Extension Study of Oral Edaravone (Radicava ORS®) Administered Over 96 Weeks in Patients with ALS (MT-1186-A03)

Author:Genge, Angela   Pattee, Gary   Sobue, Gen   Aoki, Masashi   Yoshino, Hiide   Couratier, Philippe   Lunetta, Christian   Petri, Susanne   Selness, Daniel   Todorovic, Vesna   Hirai, Manabu   Salah, Alejandro   Apple, Stephen   Wamil, Art   Kalin, Alexander   Jackson, Carlayne A.   

Session Name:S27: General Neurology 2  

Topic:General Neurology  

Program Number:S27.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  University of Nebraska Medical Center, Lincoln, NE  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Aichi, Japan  Tohoku University School of Medicine, Sendai, Miyagi, Japan  Neurology Clinic, Chiba, Japan  CRMR SLA Service de Neurologie, CHU de Limoges, Limoges, France  Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Unit of Milano , Milan, Italy  Hannover Medical School, Hannover, Germany  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe Ltd., London, United Kingdom  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  University of Texas Health Science Center at San Antonio, San Antonio, TX  

  • View Abstract
  • View Disclosure

Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls

Author:Takahashi, Fumihiro   Genge, Angela   Yoneoka, Takatomo   Hirai, Manabu   Selness, Daniel   Todorovic, Vesna   Wamil, Art   Sasson, Nissim   Apple, Stephen   Yoshiteru, Ushirogawa   

Session Name:P8: General Neurology: Motor Neuron Disease 1  

Topic:General Neurology  

Program Number:P8.003  

Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma Europe, Ltd, London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com